Evidence map›Paper›PMID 24616095›Full record

ArticleThe Journal of biological chemistry2014

After embedding in membranes antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilization.

Jingzhen Ding, Blaine H M Mooers, Zhi Zhang, Justin Kale, Domina Falcone, Jamie McNichol, Bo Huang, Xuejun C Zhang, Chengguo Xing, David W Andrews and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe.International journal of molecular sciences · 2020
    Review
  20. Bcl-2-Protein Family as Modulators of IPCold Spring Harbor perspectives in biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Jingzhen DingDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126.
Blaine H M MooersDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126.
Zhi ZhangDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126.
Justin KaleDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
Domina FalconeDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
Jamie McNicholDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
Bo HuangInstitute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Xuejun C ZhangInstitute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Chengguo XingDepartment of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455.
David W AndrewsDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada; Biological Sciences, Sunnybrook Research Institute and Department of Biochemistry, University of Toronto, Toronto, Ontario M4N 3M5, Canada.
Jialing LinDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73126. Electronic address: jialing-lin@ouhsc.edu.
McMaster University · CAUniversity of Oklahoma · USChinese Academy of Sciences · CNInstitute of Biophysics · CNUniversity of Minnesota · USUniversity of Oklahoma Health Sciences Center · USUniversity of Toronto · CA

Funding

Structure-Function Studies of MsvR, a Methanogen-Specific Transcriptional RegulaP20GM103640 · NIGMS · UNIVERSITY OF OKLAHOMA · PI MOOERS, BLAINE H. M. · 2012 to 2021
$20.4M
Structure-Function of Bcl-2 Related Apoptosis Regulators in MembranesR01GM062964 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LIN, JIALING · 2001 to 2014
$3.3M
Mechanisms of Anticancer Agents Selective against Drug Resistant LeukemiaR01CA163864 · NCI · UNIVERSITY OF MINNESOTA · PI XING, CHENGGUO · 2012 to 2016
$1.5M
The role of non-canonical base pairs in RNA editingR01AI088011 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI MOOERS, BLAINE H. M. · 2012 to 2015
$1.4M
CIHR FRN 12517NCI NIH HHS R01 CA163864NIAID NIH HHS R01 AI088011NIAID NIH HHS R01AI088011NIGMS NIH HHS P20 GM103640NIGMS NIH HHS P20GM103640NIGMS NIH HHS R01 GM062964NIGMS NIH HHS R01GM062964
6 · The paper itself

Abstract

Bcl-XL binds to Bax, inhibiting Bax oligomerization required for mitochondrial outer membrane permeabilization (MOMP) during apoptosis. How Bcl-XL binds to Bax in the membrane is not known. Here, we investigated the structural organization of Bcl-XL·Bax complexes formed in the MOM, including the binding interface and membrane topology, using site-specific cross-linking, compartment-specific labeling, and computational modeling. We found that one heterodimer interface is formed by a specific interaction between the Bcl-2 homology 1-3 (BH1-3) groove of Bcl-XL and the BH3 helix of Bax, as defined previously by the crystal structure of a truncated Bcl-XL protein and a Bax BH3 peptide (Protein Data Bank entry 3PL7). We also discovered a novel interface in the heterodimer formed by equivalent interactions between the helix 1 regions of Bcl-XL and Bax when their helical axes are oriented either in parallel or antiparallel. The two interfaces are located on the cytosolic side of the MOM, whereas helix 9 of Bcl-XL is embedded in the membrane together with helices 5, 6, and 9 of Bax. Formation of the helix 1·helix 1 interface partially depends on the formation of the groove·BH3 interface because point mutations in the latter interface and the addition of ABT-737, a groove-binding BH3 mimetic, blocked the formation of both interfaces. The mutations and ABT-737 also prevented Bcl-XL from inhibiting Bax oligomerization and subsequent MOMP, suggesting that the structural organization in which interactions at both interfaces contribute to the overall stability and functionality of the complex represents antiapoptotic Bcl-XL·Bax complexes in the MOM.

Indexed as

ApoptosisAmino Acid Sequencebcl-2-Associated X Proteinbcl-X ProteinBinding SitesDimerizationMitochondriaModels, MolecularMolecular Sequence DataPermeabilityProto-Oncogene Proteins c-bcl-2bcl-2-Associated X Proteinbcl-X ProteinProto-Oncogene Proteins c-bcl-2BaxBcl-2 ProteinsBcl-XLMembrane ProteinsMitochondrial ApoptosisProtein Cross-linking

Identifiers

PMID24616095
PMCPMC4002096
OpenAlexW1999601929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.